Skip to main content
Back
Watch Compare

MARIMED INC.

Data quality: 100%
MRMD
OTC Manufacturing Chemicals
$0.07
▲ $0.00 (6.06%)
Mkt Cap: 26.26 M
Price
$0.07
Mkt Cap
26.26 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 7.10% annually over 5 years — modest growth
Generating 6.53 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.92%
Capital efficient — spends only 0.73% of revenue on capex

Growth

Revenue Growth (5Y)
7.10%
Above sector avg (1.82%)
Revenue (1Y)1.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-25.69%
Above sector avg (-54.01%)
ROIC-1.47%
Net Margin-9.06%
Op. Margin-1.76%

Safety

Debt / Equity
1.40
Above sector avg (0.30)
Current Ratio1.06
Interest Coverage-0.38

Valuation

PE (TTM)
-1.81
Below sector avg (-1.49)
P/B Ratio0.48
EV/EBITDA18.13
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -1.8 -1.5
P/B 0.5 1.6
ROE % -25.7 -54.0
Net Margin % -9.1 -41.5
Rev Growth 5Y % 7.1 1.8
D/E 1.4 0.3

Analyst Price Target

1 analyst
Buy
Current
$0.07
+257.1%
Target
$0.25
$0.25
$0.25
$0.25
Forecast
Forward EPS -$0.03
Est. Revenue 171.70 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.03
-$0.04 – -$0.02
 171.70 M 2
FY2026 -$0.05
-$0.05 – -$0.04
 162.13 M 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.01 $0.01 +157.0%
Q32025 -$0.01 $0.00 +20.0%
Q22025 -$0.01 $0.00 +109.9%
Q12025 -$0.01 -$0.01 -0.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 1.18% Revenue Growth (3Y) 3.71%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7.10% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 159.83 M Net Income (TTM) -14.48 M
ROE -25.69% ROA -7.07%
Gross Margin 36.22% Operating Margin -1.76%
Net Margin -9.06% Free Cash Flow (TTM) 6.53 M
ROIC -1.47% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.40 Current Ratio 1.06
Interest Coverage -0.38 Asset Turnover 0.78
Working Capital 3.51 M Tangible Book Value 13.65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.81 Forward P/E N/A
P/B Ratio 0.48 P/S Ratio 0.16
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 18.13 Fwd EV/EBITDA N/A
Forward P/S 0.15 Fwd Earnings Yield N/A
FCF Yield 24.86%
Market Cap 26.26 M Enterprise Value 95.90 M
Per Share
EPS (Diluted TTM) -0.04 Revenue / Share 0.40
FCF / Share 0.02 OCF / Share 0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.73% FCF Conversion -45.07%
SBC-Adj. FCF 4.77 M Growth Momentum -5.92

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 159.83 M 157.96 M 148.60 M 134.01 M 121.46 M
Net Income -14.48 M -12.16 M -16.03 M 13.47 M 7.22 M
EPS (Diluted) -0.04 -0.03 -0.04 0.04 0.02
Gross Profit 57.88 M 62.87 M 65.92 M 63.96 M 66.26 M
Operating Income -2.82 M 2.91 M 14.39 M 20.37 M 26.86 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 8.11 M 7.91 M 5.55 M — —
Interest Expense 7.50 M 6.94 M 9.19 M 1.69 M 2.36 M
Income Tax 3.59 M 8.16 M 9.41 M 5.89 M 16.19 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 202.57 M 206.99 M 196.12 M 152.20 M 123.20 M
Total Liabilities 137.83 M 128.11 M 107.21 M 57.17 M 49.18 M
Shareholders' Equity 50.01 M 59.88 M 69.91 M 57.31 M 36.30 M
Total Debt 76.04 M 78.19 M — — —
Cash & Equivalents — 7.28 M 14.65 M 9.74 M 29.68 M
Current Assets 59.29 M 53.51 M 51.43 M 44.15 M 44.61 M
Current Liabilities 59.07 M 48.68 M 30.86 M 26.49 M 27.22 M